Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Spinal cord infections].

S Olindo1, R Deschamps, D Smadja

  • 1Service de neurologie Hôpital Pierre Zobda-Quitman 97261 Fort-de-France. grenam@outremer.com

La Revue Du Praticien
|August 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French guidelines for the diagnosis and management of MOG antibody-associated disease.

Revue neurologique·2025
Same author

An outpatient TIA clinic works! Insights from the creation and the first year of Bordeaux TIA clinic.

Revue neurologique·2025
Same author

Remote neurological evaluation reliably identifies patients eligible to endovascular therapy while non-eligible to intravenous thrombolysis.

Revue neurologique·2024
Same author

Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society.

Revue neurologique·2022
Same author

Sequential intracorneal ring segment implantation followed by transepithelial phototherapeutic keratectomy and corneal cross-linking.

Journal francais d'ophtalmologie·2022
Same author

Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus?

Revue neurologique·2022
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
Same journal

[Summary Ischemic stroke in children].

La Revue du praticien·2026
Same journal

[Treatment type 1 diabetes in children].

La Revue du praticien·2026
Same journal

[Diagnostic and therapeutic strategies for small-bowel gastrointestinal bleeding when initial upper endoscopy and colonoscopy are unremarkable].

La Revue du praticien·2026
Same journal

[Non-portal hypertension-related upper gastrointestinal bleeding].

La Revue du praticien·2026
See all related articles

Diagnosing rare infectious myelopathies like Lyme disease, vacuole myelopathy (HIV), and HTLV-I myelopathy is vital for patient outcomes. Early diagnosis guides treatment, though some conditions lack specific therapies.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Context:

  • Infectious myelopathies, though rare, necessitate accurate etiological diagnosis for improved patient outcomes.
  • Lyme disease, HIV, and Human T-cell lymphotropic virus type I (HTLV-I) are key causes of myelopathy with distinct clinical presentations.
  • Diagnostic approaches rely on serological and cerebrospinal fluid antibody testing, alongside exclusion of other spinal cord diseases.

Purpose:

  • To highlight the importance of diagnosing infectious myelopathies.
  • To differentiate between Lyme disease, vacuole myelopathy, and HTLV-I myelopathy.
  • To outline diagnostic strategies and treatment considerations for these rare neurological conditions.

Summary:

  • Lyme disease causes myelomeningoradiculitis or encephalomyelitis, diagnosed via antibody tests, and often treated with ceftriaxone or doxycycline.

Related Experiment Videos

  • Vacuole myelopathy in HIV patients presents as progressive paraparesis and dementia, with no specific treatment available.
  • HTLV-I myelopathy, endemic in tropical regions, causes chronic spastic paraparesis and dysfunction, diagnosed by antibody response and exclusion, with no specific treatment.

    • Impact:

    • Accurate diagnosis of infectious myelopathies is crucial for timely and appropriate management, potentially improving neurological outcomes.
    • Understanding the specific etiology guides therapeutic decisions, even in cases where definitive treatments are limited.
    • This review emphasizes the need for vigilance in identifying these rare but significant causes of spinal cord dysfunction.